Primary localized laryngeal amyloidosis: Report of 3 cases with long-term follow-up and review of the literature

Archives of Pathology and Laboratory Medicine

Volumn 129, Issue 2, 2005, Pages 215-218

  Ma, Linglei ^a,b   Bandarchi, Bizhan ^a   Sasaki, Clarence ^a   Levine, Steven ^a   Choi, Young ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PARAPROTEIN;

ADULT; AMYLOIDOSIS; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; FOLLOW UP; HISTOPATHOLOGY; HOARSENESS; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNX AMYLOIDOSIS; LARYNX DISORDER; LARYNX MUCOSA; LARYNX MUSCLE; LIGHT CHAIN; LYMPHOCYTIC INFILTRATION; MALE; PLASMA CELL; RECURRENT DISEASE; TISSUE SECTION; VOCAL CORD;

ADULT; AMYLOIDOSIS; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL DISEASES; MALE; MIDDLE AGED; TIME;

EID: 13444278871     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. von Rokitansky KF. Handbuch der pathologischen Anatomie. Vienna, Austria: Braumuller & Seidel; 1842:209-249.
2. Virchow R. Bav and Zussmmersetzying der Corporci Amalacca des Menschen. Vehr Phys Med Geswurzlurg. 1851;2:51-53.
3. Chow LT, Chow WH, Shum BS. Fatal massive upper respiratory tract haemorrhage: an unusual complication of localized amyloidosis of the larynx. J Laryngol Otol. 1993;107:51-53.
4. Borow A. Amyloide Degenaeration von Larynxtumoren: Canule seiber jahre lang Getrager. Arch Klin Chir. 1873;15:242-246.
5. Kennedy TL, Patel NM. Surgical management of localized amyloidosis. Laryngoscope. 2000;110:918-923.
6. Glenner GG. Amyloid deposits and amyloidosis: the beta-fibrilloses (first of two parts). N Engl J Med. 1980;302:1283-1292.
7. Glenner GG. Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts). N Engl J Med. 1980;302:1333-1343.
8. Preud'Homme JL, Ganeval D, Grunfeld JP, et al. Immunoglobulin synthesis in primary and myeloma amyloidosis. Clin Exp Immunol. 1988;73:389-394.
9. Lewis JE, Olsen KD, Kurtin PJ, Kyle RA. Laryngeal amyloidosis: a clinico-pathologic and immunohistochemical review. Otolaryngol Head Neck Surg. 1992;106:372-377.
10. Westermark P, Sletten K, Pitkanen P, Natvig J, Lindholm C. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL. Mol Immunol. 1982;19:447-450.
11. Berg AM, Troxler RF, Grillone G, et al. Localized amyloidosis of the larynx: evidence for light chain composition. Ann Otol Rhinol Laryngol. 1993;102:884-889.
12. Solomon A, Kyle RA, Frangione B. Light chain variable region subgroups of monoclonal immunoglobulins in amyloidosis AL. In: Amyloidosis. New York, NY: Plenum Press; 1986:449-462.
13. Nagasaka T, Lai R, Kuno K, Nakashima T, Nakashima N. Localized amyloidosis and extramedullary plasmacytoma involving the larynx of a child. Hum Pathol. 2001;32:132-134.
14. Pribitkin E, Friedman O, O'Hara B, et al. Amyloidosis of the upper aerodigestive tract. Laryngoscope. 2003;113:2095-2101.
15. Pepys MB, Herbert J, Hutchinson WL, et al. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature. 2002;417:254-259.